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Abstract (97/100) 
Genetic testing is becoming increasingly available for adolescents who are undergoing cancer 
treatment or at risk of cancer predisposition syndromes. With this narrative review, we aimed 
to synthesize the evidence on psychosocial outcomes and adolescents’ understanding of 
genetic testing – thus far, an under-researched topic. Both psychological benefits and harms 
of predictive testing were reported in adolescents from high-risk families. Harms were mainly 
related to cancer-specific distress and increased worries. Findings on genetic understanding 
were sparse. Future studies should focus on psychosocial outcomes and adolescents’ 
understanding undergoing genetic testing and enabling access to genetic counselling pre- and 
post-testing. 
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Introduction 
Genetic testing and screening for cancer predisposition syndromes can be effective in 
reducing cancer morbidity and mortality in adolescents1 However, adolescent and young 
adult cancers may differ from paediatric and adult cancers biologically and genetically.2-4 An 
adolescent with a pathogenic APC variant (which causes familial .improves survival and 
quality of life.5 Other adolescents have a cancer suggesting a rare broader cancer 
predisposition syndrome such as Li Fraumeni syndrome, which has implications for their 
treatment and cancer risk for their relatives.6 Other traditionally ‘adult’ cancers such as Lynch 
syndrome or breast and/or ovarian cancer syndromes are not normally tested for in 
adolescence but can rarely occur in adolescents in high risk families.2 
 
Whole genome sequencing or exome sequencing, and interest in genetic testing and 
personalized medicine for adolescents is growing.7 Increasing awareness of genetic 
syndromes, may be of value to adolescents in different contexts, including 1) enabling 
adolescent cancer patients to explore more treatment options 2) highlighting risks to 
adolescent survivors of childhood cancers, and 3) alerting adolescents who do not have 
cancer of their future cancer risk. 
 
First, for adolescents who do not respond favourably to standard cancer treatments, 
identifying a germline or somatic mutation may allow clinicians to offer treatment regimens, 
personalized to their genetic profile.4 Personalized medicine is also becoming more common 
in this age group even at diagnosis. Second, genetic testing for adolescents may also be 
important during follow-up care of childhood cancer survivors8 depending on their family 
history, medical history and tumour type.8 The uptake of a genetic test is likely dependant on 
the possible treatment options and therefore future testing should be a function of disease 
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penetrance regardless of age.9 Finally, at risk adolescents who have not had cancer could 
benefit from predictive testing to clarify their risk and allow creation of a tailored 
surveillance plan.10,11 Genetic testing in this context may be valuable however, guidelines, 
recommended surveillance protocols and available preventative actions differ for different 
genes. Typically, genetic testing is recommended if the disease is likely to manifest during 
adolescence and effective screening and intervention programs have the potential to reduce 
morbidity and mortality.12 In the context of BRCA1 and 2 mutations, interventions such as 
prophylactic surgery or chemoprevention are usually not recommended before the age of 25 
years, making genetic testing in adolescence less clinically relevant.13,14 However, testing in 
adolescents might still be salient as parents discuss cancer risk with their adolescent 
offspring, which might influence their child’s concerns. Offering genetic testing and 
personalized medicine to adolescents raises a number of psychosocial, ethical and legal 
issues. These include concerns around adolescents’ ability to understand complex genetic 
concepts and anticipate the often lifetime consequences of their decisions to enable fully 
informed consent.14,15 Further issues regarding adolescents’ age include how best to involve 
the adolescent to their full capacity while respecting that parents may need to have input into 
the consent and shared decision making processes6. As adolescents’ maturity levels vary 
widely some adolescents want to make their own decisions but are legally not able to while 
others, even though legally able, rely more on their parents.16  
A recent systematic review on the psychological impact of acquiring genetic 
knowledge in childhood and early adolescence indicated that while no major psychological 
distress was reported, there were feelings of discrimination and guilt/regret, and in some 
cases intra-familial distress.17 In adults undergoing predictive genetic testing, several factors 
appeared to influence testees’ psychological health. Feelings of uncertainty, distress and 
worry before undergoing testing and feelings of relief, reassurance or guilt after receiving a 
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negative test result were also common.18 It is clear though that genetic testing impacts are 
variable across groups, for example, patients with different types of cancer can have differing 
responses, perhaps reflecting variable risk management options.9 
While there have been reviews of the psychosocial impact of genetic testing in 
childhood 17 and adulthood 9, the impact of genetic testing during adolescence is 
understudied. In this narrative review, we explore the available literature, identify gaps and 
summarize the available recommendations for appropriately managing cancer-related genetic 
testing and personalized medicine in adolescents. The main focus will be on the psychosocial 
impact of genetic testing and adolescents’ understanding of, and knowledge about, genetics. 
 
Methods 
We performed a narrative review based on Economic and Social Research Council 
guidance.19 This form of review provides a broad overview of available evidence.20 To search 
for relevant articles we used three databases (Medline, EMBASE and PsycINFO) and the 
following search terms: ([adolescen$ OR “young adult” OR teen$] AND [oncol$ OR cancer] 
AND [personalised medicine OR personalized medicine OR genet$]).” To search for grey 
literature, we used OpenGrey and Grey Literature Report. The search was limited to English 
language and human studies which were published between 2001-2017. The initial search 
was performed in October 2015 and updated in August 2017. For the purpose of this review 
we only included studies focusing on adolescents aged 10-19 years to capture the unique 
developmental challenges and legal and ethical issues which differ from their younger and 
older counterparts. We excluded studies if results for adolescents and young adults were not 
separately discussed. 
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Three reviewers identified key articles by title and abstract screening (JF, KM, JV). 
Additional articles were obtained by searching reference lists of included articles, 
publications of recognized experts and hand searches on Google Scholar. Three investigators 
selected articles with the most relevance and potential impact to guide the findings of the 
review (JV, JF, CW).  
 
Results 
We screened 310 titles/abstracts and included a total of 9 articles. Most studies were 
published in the US, Australia and UK (n=8). 
Psychosocial impact of family history and genetic testing in adolescents  
There is little information available on the psychosocial impact of predictive genetic 
testing in adolescents from high-risk families. The largest published study of the psychosocial 
impact of a positive family history of breast cancer (incl. BRCA) of more than 250 11-19 
year old girls reported that psychosocial adjustment did not differ between girls with a strong 
family history of breast cancer and those without.21 Girls with a family history of breast 
cancer had higher self-esteem than girls without a family history.21 However girls from breast 
cancer families and BRCA1/2 positive families had higher distress than girls who were 
identified as population risk.21 The study showed positive associations for breast cancer-
specific distress in girls who perceived a high risk and in mothers who had a higher cancer-
related distress.21 Another study of 55 daughters (aged on average 15.6 years) of women with 
breast cancer reported increased worries about their future health and genetic risk for breast 
cancer compared with the control daughters.22 However, there was no evidence of additional 
emotional, behavioural or familial impact.22 Girls whose mothers had breast cancer reported 
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more benefits of undergoing genetic testing, however both groups were equally willing to 
undergo  testing.22 
A small qualitative study reported benefits for nine adolescents (six tested positive for 
cancer predisposing genes) who actively underwent predictive testing.23 No psychological 
harms were reported by the adolescents however distress occurred around the pretesting 
process.23  
Adolescents’ understanding of genetics 
Qualitative interviews with adolescent girls from population risk (n=19) and high risk 
families (n=35) indicated that they had a limited understanding of BRCA1 and 2 genes.24 
Although they may not have known the genes, those with a family history of breast cancer 
perceived themselves to be at increased risk.24 Most appeared to acquire their cancer-related 
genetics knowledge from their mothers.24 Approximately half of the 54 participating girls 
believed that breast cancer can develop during the teenage years; these results were consistent 
between high-risk and population-risk girls.24 Another study with young people aged 12-18 
years affected by or at risk for breast cancer reported that boys’ perceived risk was minimal 
likely due to gendered disclosure.25 Another study on predictive testing for FAP 
demonstrated that young adults who had undergone FAP-testing when aged between 10-17 
years had limited understanding of the process and consequences and were often not involved 
in decision-making, but spoke about their predictive genetic test as a major life event.26  
Discussion and recommendations arising from the literature 
Research regarding the impact of and adolescents’ understanding about genetic testing 
and personalized medicine in adolescents is sparse. The identified studies reported that 
genetic testing can benefit adolescents, but can cause psychological harms such as distress in 
some young people. Adolescents’ understanding appeared limited however this needs to be 
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confirmed by future studies. Several papers provide clear recommendations for the 
appropriate management of adolescents considering genetic testing. One key 
recommendation is to limit analysis to genes of clinical relevance to the adolescents’ cancer 
and cancer treatment rather than analysing all possible genes, because of challenges with 
incidental findings and uncertainties around clinical significance of some mutations.15 A 
recent policy discussion however suggested that reporting incidental findings of genomic 
testing might be the only way of learning about the family’s cancer risk.27 The impact of 
reporting incidental findings in the setting of adolescents undergoing genetic testing for 
cancer, needs to be further explored. For adolescents considering genetic testing for adult-
onset conditions, the literature recommends that they be encouraged to consider deferring 
testing until adulthood, due to their more limited capacity for decision-making and the 
complexity of the information.15 Exceptions are noted if there are clinical reasons to test, or 
effective screening or preventative interventions are available as is the case for FAP.1,15 
Healthcare professionals should provide resources and assist adolescents and their family 
members weigh the benefits and disadvantages of genetic testing for the adolescent, to help 
them make an informed decision.1 Although younger adolescents may be unable to provide 
full consent for genetic testing, they should be included in giving assent and discussions 
about the implications of testing.28 
As others have noted, genetic counselling and testing of adolescents presents unique 
challenges related to the patients’ developmental stage.29-31 ‘Adolescent friendly care’ which 
involves, amongst other things, communicating in an age-appropriate language and 
respecting adolescents’ autonomy and capacity to engage in discussions about their health,29 
may be fostered through a close working partnership with genetic health professionals and 
experts in adolescent psychology. An ‘anticipated regret’ model, where health professionals 
present hypothetical results to the adolescent and asks how they would react to receiving that 
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result 32 is useful in helping adolescents to anticipate difficulties, and consider potential 
consequences of genetic testing. Further, healthcare professionals should be knowledgeable 
about the potential psychological impact of genetic testing and personalized medicine on 
adolescents and their families.1,15 Adolescents may benefit from developing a communication 
plan with their healthcare team, outlining who should be involved in learning genetic results 
and possible staging of information sharing depending on the maturity of the young person 
being tested.15 Healthcare professionals could facilitate access to genetic counselling and 
specialist genetic services (including a geneticist and psychosocial support) if the healthcare 
team, the adolescent, or their family, would benefit.15 This support ideally should be offered 
both before and after testing.1 This aligns with the recommendations made in the adult 
setting, where results should be disclosed in a ‘comfortable setting’ and counselling offered 
before and after testing.33 However, genetic counsellors might also be confronted by different 
challenges in the future with widespread use of personalized medicine intersecting with the 
known problems such as communication and confidentiality working with adolescents and 
this needs to be acknowledged.15,30,31 Adolescents could be offered the opportunity to discuss 
genetic testing and personalized medicine without their parents present,29 although parents 
should be involved where clinically appropriate, such as discussion of secondary findings.15 
The evidence further suggests that it is important to ensure that the adolescent understands 
the long term implications of genetic testing and personalized medicine (bearing in mind that 
adolescents may be a population less likely to, or less able to consider long term 
consequences of their decisions).15 29Further, to ensure confidentiality, if siblings are also 
tested at the same time, results should be shared individually, and testing preferably 
performed on different days.26,29 
Conclusion 
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The evidence regarding the psychosocial impact of genetic testing and personalized 
medicine during adolescence is sparse. This is particularly the case for studies with 
adolescents from high-risk families, and those who are undergoing ‘treatment-focused’ and 
predictive genetic testing. However, it is important to ensure that age-appropriate educational 
and psychosocial support is available to adolescents undergoing genetic testing. The 
implications of genetic testing ideally need to be discussed both with the adolescent alone and 
together with their family with pre- and post-test counselling whenever possible. 
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